Literature DB >> 1690867

Astrocytes and the plaques of Alzheimer's disease.

T I Mandybur1, C C Chuirazzi.   

Abstract

We demonstrated senile plaques with glial fibrillary acidic protein (GFAP) stain in prefrontal and parietal cortex and in hippocampus of 3 cases of Alzheimer's disease. A plaque seen with GFAP appeared as a nearly round, spot-like brown blush consisting of numerous fine astrocytic processes, usually surrounded by single or, more often, several astrocytic cell bodies and their thick processes. Some plaques were virtually wrapped by these processes which also penetrated to the core, often directly touching the amyloid deposit. We never saw the plaque-type astrocytic grouping and spot-like blushes in the cortex of younger nondemented controls who were plaque negative. Our observations stress the importance of the astrocyte in plaque formation, either as primary or early secondary reactions. The focal glial reaction, without the neuritic component, possibly may precede neuritic change and relate to subminimal amyloid deposits or to some other undefined change.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1690867     DOI: 10.1212/wnl.40.4.635

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  13 in total

1.  Correlation of astrocytic S100 beta expression with dystrophic neurites in amyloid plaques of Alzheimer's disease.

Authors:  R E Mrak; J G Sheng; W S Griffin
Journal:  J Neuropathol Exp Neurol       Date:  1996-03       Impact factor: 3.685

2.  Low-density lipoprotein receptor represents an apolipoprotein E-independent pathway of Aβ uptake and degradation by astrocytes.

Authors:  Jacob M Basak; Philip B Verghese; Hyejin Yoon; Jungsu Kim; David M Holtzman
Journal:  J Biol Chem       Date:  2012-03-01       Impact factor: 5.157

Review 3.  Brain injury and growth inhibitory factor (GIF)--a minireview.

Authors:  I Hozumi; T Inuzuka; S Tsuji
Journal:  Neurochem Res       Date:  1998-03       Impact factor: 3.996

4.  Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology.

Authors:  C Sturchler-Pierrat; D Abramowski; M Duke; K H Wiederhold; C Mistl; S Rothacher; B Ledermann; K Bürki; P Frey; P A Paganetti; C Waridel; M E Calhoun; M Jucker; A Probst; M Staufenbiel; B Sommer
Journal:  Proc Natl Acad Sci U S A       Date:  1997-11-25       Impact factor: 11.205

5.  A comparative immunohistochemical study of Kuru and senile plaques with a special reference to glial reactions at various stages of amyloid plaque formation.

Authors:  M Miyazono; T Iwaki; T Kitamoto; Y Kaneko; K Doh-ura; J Tateishi
Journal:  Am J Pathol       Date:  1991-09       Impact factor: 4.307

Review 6.  The role of beta-amyloid peptide in Alzheimer's disease.

Authors:  A LeBlanc
Journal:  Metab Brain Dis       Date:  1994-03       Impact factor: 3.584

7.  Receptor for advanced glycation end products is upregulated in optic neuropathy of Alzheimer's disease.

Authors:  Michelle Y Wang; Fred N Ross-Cisneros; Divya Aggarwal; Chiao-Ying Liang; Alfredo A Sadun
Journal:  Acta Neuropathol       Date:  2009-03-11       Impact factor: 17.088

8.  Decreased fractalkine and increased IP-10 expression in aged brain of APP(swe) transgenic mice.

Authors:  Rui-Sheng Duan; Xin Yang; Zhi-Guo Chen; Ming-Ou Lu; Chris Morris; Bengt Winblad; Jie Zhu
Journal:  Neurochem Res       Date:  2007-12-20       Impact factor: 3.996

9.  Role of Activated Glia and of Glial Cytokines in Alzheimer's Disease: A Review.

Authors:  R E Mrak; W St Griffin
Journal:  EOS       Date:  1996

10.  Low levels of amyloid-beta and its transporters in neonatal rats with and without hydrocephalus.

Authors:  Kelley E Deren; Jennifer Forsyth; Osama Abdullah; Edward W Hsu; Petra M Klinge; Gerald D Silverberg; Conrad E Johanson; James P McAllister
Journal:  Cerebrospinal Fluid Res       Date:  2009-05-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.